Aviado · Research
Longevity Daily
Friday, July 3, 2026
Listen
Today's Brief
Today's lead story offers a compelling, affordable angle: a rigorous twin study finds that daily protein and prebiotic supplements measurably improve memory in adults over 60, with the gut-brain axis likely driving the effect. The PROMETHEUS trial takes personalization further, tailoring NMN, urolithin A, and creatine stacks to individual biomarker profiles in an XPRIZE-backed aging protocol. New CDC data confirm U.S. life expectancy is on track for another record high, while sobering research maps how social and economic inequality — not genetics — drives accelerated biological aging in Black Americans.
10 stories2 peer-reviewed1 trials1 Aviado original
Cognitive Health & Neuroprotection
Cheap Daily Protein and Prebiotic Supplements Measurably Improve Memory in Adults Over 60
A rigorous twin study published in Nature Communications found that taking daily protein supplements alongside prebiotic fiber improved memory test scores in people over 60 -- and it has been cited nearly 100 times since 2024, signaling genuine scientific staying power. The twin design is the crucial detail: by controlling for genetics, researchers isolated the supplement effect itself, eliminating the usual confound that healthier people are simply more likely to supplement. The most likely mechanism runs through the gut-brain axis -- prebiotics shift the microbiome in ways that appear to support neurological function, a pathway with growing independent support. If you're over 60 and not yet combining protein and prebiotics, this study provides one of the stronger human-based arguments for starting.
Read more →Supplements & Compounds
PROMETHEUS Trial Tests Personalised NMN, Urolithin A, and Creatine Stacks Against Individual Aging Biomarkers
The PROMETHEUS trial, an XPRIZE healthspan semi-finalist, is testing an 8-week multimodal precision aging protocol in 20 middle-aged to older adults. Participants receive a personalised supplement stack -- whey protein, creatine, fucoidan, and NMN or urolithin A assigned based on individual muscle mass, VO2peak, and cognitive scores -- with dosing adjusted mid-trial based on interim responses, including adding ergothioneine for inadequate cognitive improvement. The study is small and exploratory (n=20), but it signals where precision geromedicine is heading: biomarker-matched supplementation rather than one-size-fits-all dosing.
Read more →Daily Multivitamin Modestly Slows Epigenetic Aging Markers Over Two Years, COSMOS Trial Shows
A new analysis from the landmark COSMOS trial found that older adults taking a daily multivitamin showed measurably slower epigenetic aging over two years compared to placebo. The effect is described as "modest" -- this isn't a dramatic reversal -- but the fact that an inexpensive, widely available supplement produces detectable changes in biological age biomarkers carries weight coming from one of the most rigorously designed supplement trials ever run. If you're already taking a multivitamin, this is reassuring confirmation; if you're not, it's a low-cost intervention with increasingly credible support.
Read more →Doctors Warn: Liver Supplement Sales Are Soaring -- and Most Products Lack Solid Evidence
As fatty liver disease diagnoses climb and social media amplifies awareness of liver health, supplement sales claiming to "support" or "cleanse" the liver have surged -- prompting warnings from hepatologists who say the evidence base for most products is thin. Business Insider spoke with liver specialists and supplement insiders who note that some products carry a real risk of drug-induced liver injury, adding harm to the lack of proven benefit. Before adding milk thistle or any detox formula to your stack, the doctors quoted here strongly favor lifestyle changes -- reduced alcohol, less processed food, more exercise -- as the only interventions with solid evidence.
Read more →Research & Papers
Social and Economic Inequality -- Not Biology -- Drives Accelerated Aging in Black Americans
A cross-sectional analysis of 2,086 adults from the Health and Retirement Study found that Black participants had significantly higher rates of accelerated biological aging versus White participants (57.1% vs. 41.8%), measured using the GrimAge DNA methylation clock. Critically, after accounting for wealth, social frailty, health behaviors, and medical conditions, the racial gap disappeared entirely -- meaning the difference is driven by structural inequalities, not intrinsic biological differences. Wealth, neighborhood environment, and social connection emerged as the most policy-actionable targets for closing the gap.
Read more →U.S. Death Rate Falls to Record Low, Putting Life Expectancy on Track for a New High in 2025
New federal mortality data from the CDC suggests U.S. life expectancy likely hit another record in 2025, driven by continued declines in death rates following the Covid-19 pandemic peak. The gains reflect compounding progress in cardiovascular disease prevention, cancer treatment, and infectious disease management at the population level. For longevity watchers, it's a useful benchmark -- the average trajectory keeps improving even as the maximum human lifespan ceiling remains stubbornly fixed.
Read more →We've Doubled Life Expectancy in 250 Years -- Now the Hard Part Begins
As the U.S. marks its 250th anniversary, life expectancy has nearly doubled from the mid-30s to almost 80 -- what Forbes contributor Joseph Coughlin calls the "first unlock" of longevity, driven by public health and medical advances. His argument is that the next challenge isn't squeezing more average years out of existing medicine, but achieving a qualitatively different second unlock: extending healthspan, not just lifespan. This is a useful macro-level counterpoint to the individual biohacking focus that dominates longevity discourse, and worth reading if you want the bigger picture.
Read more →Aviado Research: The Latest In-Depth Longevity Analysis
Aviado Research's latest review offers a deep dive into the current evidence landscape in longevity science, examining the mechanisms and data behind key interventions. The analysis prioritises rigour over hype -- a useful counterweight to the noise in this space. Click through for the full breakdown.
Read the full Aviado analysis →Lifestyle & Nutrition
The Strength Training Longevity Sweet Spot: 90-120 Minutes Per Week Cuts Death Risk by 13%
A large observational study tracking 147,374 participants over 30 years identified 90 to 120 minutes of strength training per week as the optimal dose for longevity -- linked to a 13% lower risk of all-cause mortality and a 19% lower risk of cardiovascular death. Going beyond that threshold offered diminishing returns, while less provided substantially smaller benefit. If you're already doing cardio but skipping resistance training, these numbers make a straightforward case for adding two dedicated sessions per week.
Read more →